Just Healthcare

Just Healthcare

Share this post

Just Healthcare
Just Healthcare
Bempedoic Acid: A New option for Statin-Intolerant Patients
Copy link
Facebook
Email
Notes
More

Bempedoic Acid: A New option for Statin-Intolerant Patients

Exploring Bempedoic Acid's Role in Preventing Cardiovascular Events

Naveen Sankar S's avatar
Naveen Sankar S
Mar 24, 2024
∙ Paid

Share this post

Just Healthcare
Just Healthcare
Bempedoic Acid: A New option for Statin-Intolerant Patients
Copy link
Facebook
Email
Notes
More
Share

Topline:

A recent subgroup analysis from the CLEAR Outcomes trial highlights bempedoic acid's significant potential in reducing major adverse cardiovascular events (MACE) among high-risk, statin-intolerant patients. This finding marks a pivotal moment for patients and healthcare providers, promising a new, effective treatment path for those previously l…

Keep reading with a 7-day free trial

Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Just Healthcare
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More